ligands acting on targets

(R)-Funapide ((R)-TV 45070) is the less active R-enantiomer of Funapide. Funapide is a potent Nav1.7 sodium channel blocker that can be used for pain researchForm:SolidIC50&amp: Target:Na v 1.7.

(R)-Funapide ((R)-TV 45070) is the less active R-enantiomer of Funapide. Funapide is a potent Nav1.7 sodium channel blocker that can be used for pain researchIC50&amp: Target:Na v 1.7.

Information(R)-GNE-140 (R)-GNE-140 is a selective inhibitor of the LDHA and LDHB with IC50s of 3 nM and 5 nM, respectively. The R enantiomer of GNE-140 is 18-fold more potent than S enantiomer.TargetsLDHA (Cell-free assay): LDHB (Cell-free assay) 3

Information(R)-GNE-140 (R)-GNE-140 is a selective inhibitor of the LDHA and LDHB with IC50s of 3 nM and 5 nM, respectively. The R enantiomer of GNE-140 is 18-fold more potent than S enantiomer.TargetsLDHA (Cell-free assay): LDHB (Cell-free assay) 3

Information(R)-GNE-140 (R)-GNE-140 is a selective inhibitor of the LDHA and LDHB with IC50s of 3 nM and 5 nM, respectively. The R enantiomer of GNE-140 is 18-fold more potent than S enantiomer.TargetsLDHA (Cell-free assay): LDHB (Cell-free assay) 3

Information(R)-GNE-140 (R)-GNE-140 is a selective inhibitor of the LDHA and LDHB with IC50s of 3 nM and 5 nM, respectively. The R enantiomer of GNE-140 is 18-fold more potent than S enantiomer.TargetsLDHA (Cell-free assay): LDHB (Cell-free assay) 3

Information(R)-GNE-140 (R)-GNE-140 is a selective inhibitor of the LDHA and LDHB with IC50s of 3 nM and 5 nM, respectively. The R enantiomer of GNE-140 is 18-fold more potent than S enantiomer.TargetsLDHA (Cell-free assay): LDHB (Cell-free assay) 3

Information(R)-GNE-140 (R)-GNE-140 is a selective inhibitor of the LDHA and LDHB with IC50s of 3 nM and 5 nM, respectively. The R enantiomer of GNE-140 is 18-fold more potent than S enantiomer.TargetsLDHA (Cell-free assay): LDHB (Cell-free assay) 3

(R)-GSK-3685032 is the R-enantiomer of GSK-3685032. GSK-3685032 is a non-time-dependent, noncovalently, first-in-class reversible DNMT1 -selective inhibitor, with an IC 50 of 0.036 μM. GSK-3685032 induces robust loss of DNA methylation,

(R)-GSK-3685032 is the R-enantiomer of GSK-3685032. GSK-3685032 is a non-time-dependent, noncovalently, first-in-class reversible DNMT1 -selective inhibitor, with an IC 50 of 0.036 μM. GSK-3685032 induces robust loss of DNA methylation,

(R)-Irsenontrine ((R)-E2027), the R-enantiomer of Irsenontrine ( HY-132821 ), is a potent phosphodiesterase 9 (PDE9) inhibitor with an IC 50 value of 0.041 μM. (R)-Irsenontrine can be used for the research of neurological diseasesForm:SolidIC50&amp:

(R)-Irsenontrine ((R)-E2027), the R-enantiomer of Irsenontrine ( HY-132821 ), is a potent phosphodiesterase 9 (PDE9) inhibitor with an IC 50 value of 0.041 μM. (R)-Irsenontrine can be used for the research of neurological diseasesForm:SolidIC50&amp: